Abnova FISH probes for cancer research
Abnova provides a collection of fluorescence in situ hybridisation (FISH) probes targeting various potential prognostic biomarkers for oncology. The company’s cytogenetic probes enable high hybridisation efficiency, ready for the rapid identification of chromosomal abnormalities — such as amplifications, translocation, fusion and splitting — that are frequently encountered across the genome.
Designed for the purpose of pinpointing DNA targets in cells and in tissues, the FISH probes will facilitate further research for lung adenocarcinoma, ovarian cancer, pancreatic cancer, prostate cancer and more.
Phone: 02 9698 2022
Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium
The products provide researchers and manufacturers with high-performance, scalable and...
Grace Bio-Labs protein microarray tools
Grace Bio-Labs' microarray substrates provide high binding capacity and enable high assay...
Siemens Healthineers 3gAllergy assay
Siemens Healthineers has expanded its 3gAllergy assay menu with nine additional component...
